Robert A. Archer
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert A. Archer.
Journal of Organic Chemistry | 1977
Robert A. Archer; W. B. Blanchard; William A. Day; Douglas W. Johnson; Edward Ralph Lavagnino; C. W. Ryan; Jack E. Baldwin
Aufgrund des klinischen Interesses von Nabilon (VIa) werden verschiedene Synthesen zur Herstellung dieser Verbindung beschrieben, die an bekannte Verfahren anschliesen.
Cellular and Molecular Life Sciences | 1972
E. Wenkert; D. W. Cochran; F. M. Schell; Robert A. Archer; K. Matsumoto
Die13C-NMR-Spektren des Tetrahydrocannabinols und seiner Isomeren wurden aufgenommen und vollständig analysiert.
Cellular and Molecular Life Sciences | 1977
Bernard J. Abbott; David S. Fukuda; Robert A. Archer
Microorganisms were screened for their ability to modify 2 synthetic cannabinoid substrates (I andII). Structure analyses revealed that microorganisms transformed the substrates by (a) primary oxidation of the side chain, β-oxidation of the side chain, ketone formation on the side chain or cyclohexene ring, (b) secondary hydroxylation on the side chain, (c) aromatization of the cyclohexene ring, and (d) tertiary hydroxylation at the b/c ring juncture.
Archive | 1979
Robert A. Archer; William A. Day
Archive | 1973
Robert A. Archer; Ken Matsumoto
Journal of Organic Chemistry | 1977
Robert A. Archer; Douglas W. Johnson; Edward W. Hagaman; Louis N. Moreno; Ernest Wenkert
Archive | 1976
Robert A. Archer; Louis Lemberger
Archive | 1976
Robert A. Archer
Archive | 1976
Robert A. Archer; Louis Lemberger
Drug Development Research | 1984
Martin D. Hynes; Leander J. David; Robert C.A. Frederickson; P. K. Ho Peter; Douglas W. Johnson; Robert A. Archer